Pfizer and BioNTech announced this week that their vaccine was 90 percent effective at preventing symptomatic COVID-19 in clinical trials.
CU Anschutz
Fitzsimons Building
13001 East 17th Place
Aurora, CO 80045
Pfizer’s announcement shows the promise of gene-based vaccines
Default sub title
minute read
by The Verge | November 12, 2020
